Tags » Cushing's Syndrome
Corcept markets Korlym® for the treatment of Cushing’s syndrome, a severe orphan illness that afflicts 20,000 people in the United States, approximately half of whom are cured by surgery. 46 more words
Endocrinology Today 02/2015; 4(1):30-35.
Clinical recognition of Cushing’s syndrome should generally follow from the observation of a constellation of compatible clinical features that progress over time. 68 more words